IntegraMed America Inc. (INMD, Financial) filed Amended Annual Report for the period ended 2008-12-31.
IntegraMed America, Inc. is a physician practice management company which provides comprehensive management support services to a network of medical providers of women's health care services. The Company's objective is to create and manage a nationwide Network of medical providers of specialty women's health care services that achieves high quality clinical outcomes with maximum cost effectiveness. Integramed America Inc. has a market cap of $71.83 million; its shares were traded at around $8.18 with a P/E ratio of 16.36 and P/S ratio of 0.36. Integramed America Inc. had an annual average earning growth of 23.5% over the past 5 years.
effects:
2008 2007 2006
- - -
Revenue as reported ............................... $ 197,403 $ 151,166 $ 125,818
Net Change in reported revenue .................... 750 656 502
- - -
Revenue as restated ............................... $ 198,153 $ 151,822 $ 126,320
= = =
Income before income taxes as reported ............ $ 5,715 $ 4,062 $ 3,047
Net change in reported revenue .................... 750 656 502
Net change in reserve for medical costs ........... (13) (12) (9)
- - -
Income before income taxes as restated ............ $ 6,452 $ 4,706 $ 3,540
= = =
Income tax provision as reported .................. $ 2,227 $ 1,391 $ 263
Net change in income taxes from above adjustments . 310 271 207
- - -
Income tax provision as restated .................. $ 2,537 $ 1,662 $ 470
= = =
Net income as reported ............................ $ 3,488 $ 2,671 $ 2,784
Summary of above adjustments ...................... 427 373 286
- - -
Net income as restated ............................ $ 3,915 $ 3,044 $ 3,070
= = =
Diluted earnings per share as reported ............ $ 0.40 $ 0.32 $ 0.34
Change in earnings per share from above adjustments 0.05 0.04 0.03
- - -
Diluted earnings per share as restated ............ $ 0.45 $ 0.36 $ 0.37
= = =
Current liabilities as reported ................... $ 51,126 $ 44,005 $ 27,856
Cumulative effect of restatement on liabilities ... (1,513) (1,086) (712)
- - -
Current liabilities as restated ................... $ 49,613 $ 42,919 $ 27,144
= = =
Shareholders' Equity as reported .................. $ 50,753 $ 46,549 $ 39,466
Cumulative effect of restatement on
Shareholders' Equity .......................... 1,511 1,085 712
- - -
Shareholders' Equity as restated .................. $ 52,264 $ 47,634 $ 40,178
= = =
Read the The complete Report
IntegraMed America, Inc. is a physician practice management company which provides comprehensive management support services to a network of medical providers of women's health care services. The Company's objective is to create and manage a nationwide Network of medical providers of specialty women's health care services that achieves high quality clinical outcomes with maximum cost effectiveness. Integramed America Inc. has a market cap of $71.83 million; its shares were traded at around $8.18 with a P/E ratio of 16.36 and P/S ratio of 0.36. Integramed America Inc. had an annual average earning growth of 23.5% over the past 5 years.
Highlight of Business Operations:
The change in the timing related to revenue recognition had the followingeffects:
2008 2007 2006
- - -
Revenue as reported ............................... $ 197,403 $ 151,166 $ 125,818
Net Change in reported revenue .................... 750 656 502
- - -
Revenue as restated ............................... $ 198,153 $ 151,822 $ 126,320
= = =
Income before income taxes as reported ............ $ 5,715 $ 4,062 $ 3,047
Net change in reported revenue .................... 750 656 502
Net change in reserve for medical costs ........... (13) (12) (9)
- - -
Income before income taxes as restated ............ $ 6,452 $ 4,706 $ 3,540
= = =
Income tax provision as reported .................. $ 2,227 $ 1,391 $ 263
Net change in income taxes from above adjustments . 310 271 207
- - -
Income tax provision as restated .................. $ 2,537 $ 1,662 $ 470
= = =
Net income as reported ............................ $ 3,488 $ 2,671 $ 2,784
Summary of above adjustments ...................... 427 373 286
- - -
Net income as restated ............................ $ 3,915 $ 3,044 $ 3,070
= = =
Diluted earnings per share as reported ............ $ 0.40 $ 0.32 $ 0.34
Change in earnings per share from above adjustments 0.05 0.04 0.03
- - -
Diluted earnings per share as restated ............ $ 0.45 $ 0.36 $ 0.37
= = =
Current liabilities as reported ................... $ 51,126 $ 44,005 $ 27,856
Cumulative effect of restatement on liabilities ... (1,513) (1,086) (712)
- - -
Current liabilities as restated ................... $ 49,613 $ 42,919 $ 27,144
= = =
Shareholders' Equity as reported .................. $ 50,753 $ 46,549 $ 39,466
Cumulative effect of restatement on
Shareholders' Equity .......................... 1,511 1,085 712
- - -
Shareholders' Equity as restated .................. $ 52,264 $ 47,634 $ 40,178
= = =
Read the The complete Report
